JP2019535658A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019535658A5 JP2019535658A5 JP2019520591A JP2019520591A JP2019535658A5 JP 2019535658 A5 JP2019535658 A5 JP 2019535658A5 JP 2019520591 A JP2019520591 A JP 2019520591A JP 2019520591 A JP2019520591 A JP 2019520591A JP 2019535658 A5 JP2019535658 A5 JP 2019535658A5
- Authority
- JP
- Japan
- Prior art keywords
- benzo
- dimethyl
- imidazol
- piperidine
- difluorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1617627.3A GB201617627D0 (en) | 2016-10-18 | 2016-10-18 | Pharmaceutical compounds |
| GB1617627.3 | 2016-10-18 | ||
| PCT/GB2017/053153 WO2018073587A1 (en) | 2016-10-18 | 2017-10-18 | Pharmaceutical compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019535658A JP2019535658A (ja) | 2019-12-12 |
| JP2019535658A5 true JP2019535658A5 (enExample) | 2020-11-26 |
| JP7082616B2 JP7082616B2 (ja) | 2022-06-08 |
Family
ID=57680679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019520591A Active JP7082616B2 (ja) | 2016-10-18 | 2017-10-18 | 医薬化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10647704B2 (enExample) |
| EP (1) | EP3529240B1 (enExample) |
| JP (1) | JP7082616B2 (enExample) |
| CN (1) | CN110036002B (enExample) |
| AU (1) | AU2017346454B2 (enExample) |
| DK (1) | DK3529240T3 (enExample) |
| ES (1) | ES2824814T3 (enExample) |
| GB (1) | GB201617627D0 (enExample) |
| HU (1) | HUE052107T2 (enExample) |
| WO (1) | WO2018073587A1 (enExample) |
| ZA (1) | ZA201902335B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201617630D0 (en) * | 2016-10-18 | 2016-11-30 | Cellcentric Ltd | Pharmaceutical compounds |
| WO2019055877A1 (en) | 2017-09-15 | 2019-03-21 | Forma Therapeutics, Inc. | TETRAHYDROIMIDAZO QUINOLINE COMPOSITIONS AS INHIBITORS OF CBP / P300 |
| KR20250067962A (ko) | 2018-06-29 | 2025-05-15 | 포르마 세라퓨틱스 인크. | Creb 결합 단백질(cbp)의 저해 |
| US12351577B2 (en) | 2019-03-15 | 2025-07-08 | Forma Therapeutics, Inc. | Inhibiting cyclic AMP-responsive element-binding protein (CREB) |
| CN112574189B (zh) * | 2019-09-27 | 2024-05-31 | 海创药业股份有限公司 | 一种ep300/cbp抑制剂 |
| CN112574191B (zh) * | 2019-09-29 | 2024-01-23 | 南京圣和药业股份有限公司 | 异噁唑杂环类化合物及其应用 |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
| TW202227429A (zh) * | 2020-11-06 | 2022-07-16 | 大陸商貝達藥業股份有限公司 | Ｐ３００抑制劑、包含其的藥物組合物、其應用及製備其的方法 |
| CN116670129A (zh) * | 2020-12-31 | 2023-08-29 | 南京明德新药研发有限公司 | 苯并咪唑类化合物及其应用 |
| CN114989158A (zh) * | 2021-03-02 | 2022-09-02 | 复旦大学 | 组蛋白乙酰转移酶p300溴结构域抑制剂及其药用组合物及其应用 |
| CN117645603A (zh) * | 2022-09-05 | 2024-03-05 | 复旦大学 | p300溴结构域抑制剂及其药用组合物及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200501960A (en) * | 2002-10-02 | 2005-01-16 | Bristol Myers Squibb Co | Synergistic kits and compositions for treating cancer |
| JP5536336B2 (ja) * | 2005-11-08 | 2014-07-02 | チョンウェ ファーマ コーポレイション | α−ヘリックス類似体および癌幹細胞の治療に関する方法 |
| US8501957B2 (en) | 2008-12-10 | 2013-08-06 | China Medical University | Benzimidazole compounds and their use as anticancer agents |
| US9005670B2 (en) * | 2010-01-05 | 2015-04-14 | The Johns Hopkins University | Use of histone acetyltransferase inhibitors as novel anti-cancer therapies |
| EP2397471A1 (en) | 2010-06-16 | 2011-12-21 | China Medical University | Benzimidazole compounds and their use |
| TWI527811B (zh) * | 2013-05-09 | 2016-04-01 | 吉李德科學股份有限公司 | 作爲溴結構域抑制劑的苯並咪唑衍生物 |
| WO2015004533A2 (en) * | 2013-06-21 | 2015-01-15 | Zenith Epigenetics Corp. | Novel substituted bicyclic compounds as bromodomain inhibitors |
| WO2016086200A1 (en) * | 2014-11-27 | 2016-06-02 | Genentech, Inc. | 4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors |
| WO2016097870A1 (en) | 2014-12-17 | 2016-06-23 | Zenith Epigenetics Corp. | Substituted bicyclic compounds as bromodomain inhibitors |
| GB201506658D0 (en) * | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| CA2994478C (en) | 2015-08-12 | 2023-10-03 | Neomed Institute | Substituted benzimidazoles, their preparation and their use as pharmaceuticals |
| GB201617630D0 (en) * | 2016-10-18 | 2016-11-30 | Cellcentric Ltd | Pharmaceutical compounds |
-
2016
- 2016-10-18 GB GBGB1617627.3A patent/GB201617627D0/en not_active Ceased
-
2017
- 2017-10-18 US US16/341,650 patent/US10647704B2/en active Active
- 2017-10-18 DK DK17790814.2T patent/DK3529240T3/da active
- 2017-10-18 WO PCT/GB2017/053153 patent/WO2018073587A1/en not_active Ceased
- 2017-10-18 ES ES17790814T patent/ES2824814T3/es active Active
- 2017-10-18 JP JP2019520591A patent/JP7082616B2/ja active Active
- 2017-10-18 CN CN201780072397.7A patent/CN110036002B/zh active Active
- 2017-10-18 AU AU2017346454A patent/AU2017346454B2/en active Active
- 2017-10-18 EP EP17790814.2A patent/EP3529240B1/en active Active
- 2017-10-18 HU HUE17790814A patent/HUE052107T2/hu unknown
-
2019
- 2019-04-12 ZA ZA2019/02335A patent/ZA201902335B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019537571A5 (enExample) | ||
| US20230346927A1 (en) | COMBINATION of ATR KINASE INHIBITORS and PD-1/PD-L1 INHIBITORS | |
| AU2013361127B2 (en) | Compounds and methods for kinase modulation, and indications therefor | |
| TWI733679B (zh) | Ｈｐｋ１抑制劑及其使用方法 | |
| JP5450434B2 (ja) | 関節炎の治療方法 | |
| AU2004289672B2 (en) | Inhibition of FGFR3 and treatment of multiple myeloma | |
| RU2016129953A (ru) | Фармацевтические комбинации | |
| JP2019517487A5 (enExample) | ||
| JP2023536164A5 (enExample) | ||
| RU2013151174A (ru) | Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы | |
| RU2017116598A (ru) | Соединения и композиции для модуляции киназной активности мутантов egfr | |
| US11660301B2 (en) | Combination of ATR kinase inhibitors with PARP inhibitors | |
| SI3018132T1 (en) | Condensed imidazole derivatives useful as IDO inhibitors | |
| KR20150093819A (ko) | 약제 조성물 | |
| JP2019507114A5 (enExample) | ||
| US12440494B2 (en) | Compounds useful for inhibiting RAF dimers | |
| JP2017519818A5 (enExample) | ||
| JP2012526772A5 (enExample) | ||
| JP2024542248A5 (enExample) | ||
| RU2019104609A (ru) | Производные аминопиридина и их применение в качестве селективных ингибиторов alk-2 | |
| RU2019117958A (ru) | Производные индола, полезные в качестве ингибиторов диацилглицерид-о-ацилтрансферазы 2 | |
| RU2018106498A (ru) | Производные 5-(N-конденсированный трициклический арил-тетрагидроизохинолин-6-ил) пиридин-3-ил-уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека | |
| JP2026504481A (ja) | ジアシルグリセロールキナーゼ（ｄｇｋ）阻害剤の組合せ | |
| US20210369724A1 (en) | Combination of atr kinase inhibitors with 2,3-dihydroimidazo[1,2-c]quinazoline compounds | |
| RU2018106501A (ru) | Производные 5-(N-[6,5]-конденсированный бицикличный арил-тетрагидроизохинолин-6-ил)-пиридин-3-ил-уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека |